Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
63
-
Total 13F shares, excl. options
-
24.6M
-
Shares change
-
+1.6M
-
Total reported value, excl. options
-
$71.4M
-
Value change
-
+$2.58M
-
Put/Call ratio
-
0.55
-
Number of buys
-
37
-
Number of sells
-
-34
-
Price
-
$2.90
Significant Holders of IDERA PHARMACEUTICALS INC - COM NEW (IDRA) as of Q2 2014
91 filings reported holding IDRA - IDERA PHARMACEUTICALS INC - COM NEW as of Q2 2014.
IDERA PHARMACEUTICALS INC - COM NEW (IDRA) has 63 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.6M shares
.
Largest 10 shareholders include FMR LLC (3.7M shares), Broadfin Capital, LLC (3.53M shares), NATIXIS (3.15M shares), VANGUARD GROUP INC (2.11M shares), BAKER BROS. ADVISORS LP (1.61M shares), BlackRock Fund Advisors (1.48M shares), MILLENNIUM MANAGEMENT LLC (1.05M shares), DIMENSIONAL FUND ADVISORS LP (968K shares), SABBY MANAGEMENT, LLC (617K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (605K shares).
This table shows the top 63 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.